Vanguard Group Inc. Sells 201,000 Shares of Envista Holdings Corporation $NVST

Key Points

• Vanguard Group Inc. decreased its stake in Envista Holdings Corporation (NYSE:NVST) by 1.2%, holding 17,074,365 shares valued at $294.7 million after selling 201,000 shares in the first quarter.
• Other institutional investors, including UMB Bank and Palouse Capital Management, have increased their holdings in Envista during the same period, indicating a mixed sentiment among investors.
• Envista reported earnings of $0.26 per share for the last quarter, surpassing analysts' expectations, with revenues increasing 7.7% year-over-year to $682.1 million.

Vanguard Group Inc. cut its stake in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 1.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,074,365 shares of the company's stock after selling 201,000 shares during the period. Vanguard Group Inc. owned 10.07% of Envista worth $294,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in Envista by 1,338.3% during the first quarter. GAMMA Investing LLC now owns 33,139 shares of the company's stock valued at $572,000 after purchasing an additional 30,835 shares during the period. Two Sigma Advisers LP grew its stake in shares of Envista by 66.6% during the fourth quarter. Two Sigma Advisers LP now owns 47,800 shares of the company's stock valued at $922,000 after buying an additional 19,100 shares during the last quarter. Comerica Bank grew its stake in shares of Envista by 8.2% during the fourth quarter. Comerica Bank now owns 121,851 shares of the company's stock valued at $2,350,000 after buying an additional 9,248 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Envista by 220.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 47,319 shares of the company's stock valued at $817,000 after buying an additional 32,556 shares during the last quarter. Finally, CWM LLC grew its stake in shares of Envista by 309.7% during the first quarter. CWM LLC now owns 25,928 shares of the company's stock valued at $448,000 after buying an additional 19,600 shares during the last quarter.

Envista Trading Up 5.9%

NYSE:NVST traded up $1.2090 during midday trading on Friday, hitting $21.6690. The stock had a trading volume of 1,558,799 shares, compared to its average volume of 2,653,525. Envista Holdings Corporation has a one year low of $14.22 and a one year high of $23.00. The company has a market capitalization of $3.60 billion, a price-to-earnings ratio of 67.72, a PEG ratio of 1.10 and a beta of 1.00. The stock has a 50-day moving average of $20.04 and a 200 day moving average of $18.61. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The company had revenue of $682.10 million for the quarter, compared to analysts' expectations of $638.21 million. During the same quarter in the prior year, the firm earned $0.11 earnings per share. Envista's revenue was up 7.7% compared to the same quarter last year. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. As a group, sell-side analysts forecast that Envista Holdings Corporation will post 1 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on NVST shares. Mizuho upped their target price on Envista from $15.00 to $18.00 and gave the company an "underperform" rating in a research note on Friday, August 1st. Stifel Nicolaus upped their target price on Envista from $24.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Evercore ISI upped their target price on Envista from $19.00 to $23.00 and gave the company an "outperform" rating in a research note on Wednesday, July 9th. Piper Sandler upped their target price on Envista from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Finally, Bank of America cut their target price on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $20.92.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.